What To Do Without A Second Dose Of Vaccine, Experts Say

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
What To Do Without A Second Dose Of Vaccine, Experts Say

© Scott Eisen / Getty Images News via Getty Images

In general, once someone has received the first dose of one of the COVID vaccines, they should expect toCOVID get and need, another within weeks. That might be prevented, either by lack of supply or, rarely, trouble like weather.  Experts have several answers, but at their core, the most critical one is to get the second shot as soon as possible.

There have been 69,883,625 doses of Pfizer/BioNTech distributed in America, and 50,641,884 have been given, for a number of 72%. However, while 11% of Americans have received a dose, only 3.9% have gotten a second shot, according to the CDC.

Expert worry that the vaccination pace has been too slow. They also worry that variants may not be completely treated by current vaccines and that these new variants spread very quickly, which could cause another wave of infections.

Currently, in the U.S. there are 27,837,755 confirmed cases, about a quarter of the world’s total, and 488,364, about a fifth of the world’s numbers. Fortunately, as the spread has slowed, so have hospitalizations. This is critical because some hospitals have had ICU beds overwhelmed which can compromise the quality of treatment.

According to BioNTech chief executive Professor Ugur Sahin the time between doses should not be more than six weeks. He said this in response to a U.K. decision to make the period as long as 12 weeks. He told Sky News, “As a scientist, I wouldn’t mind if the second dose of the vaccine is given three weeks, four weeks, maybe five weeks, even up to six weeks might still be okay. But I wouldn’t delay that further. As a scientist I believe that it is not good to go longer than six weeks.”

Scientific American reports that “Now the U.S. Centers for Disease Control and Prevention has updated its guidance to say that people can wait up to 42 days between doses, though the agency still advises individuals to stick to the initial schedule.”

The second dose is the one that does the most to protect people. In an article at MedPage Today, Purvi Parikh, MD, an immunologist at NYU Langone Health in New York City says “The first time the immune system comes into contact with something, it’s getting primed. That goes for everything, from vaccines to allergies. It’s rare on the first time to have a strong reaction. After that, the immune system recognizes it, so you have a much stronger reaction.”

[nativounit]

Gizmodo examined the second dose delay further. It quotes Dr. Rebecca Wurtz, Infectious disease physician and population health expert at the University of Minnesota who commented about those who have the first dose but not the second: “Until then, you have less protection—although still some—from infection and serious illness and you may shed virus if you do get infected, in contrast to better protection and less shedding if you are completely immunized.”

All of these comments boil down to one thing. The first dose largely prepares the human body for the second. Without the second, the disease remains dangerous. Don’t delay, but if you have to, get the second shot as soon as possible.

Click here to read Major Milestones in the Race to Vaccinate Every American Against COVID-19

Click here to see home many people have died of COVID-19 in every state.

[recirclink id=837556][wallst_email_signup]

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618